FDA recall record

Akorn Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cups (NDC 50383-720-15) recall — FDA D-0611-2018

Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.

Class IIIclassification
D-0611-2018official record ID
Apr 4, 2018report date

Recall record at a glance

Official recordD-0611-2018
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmAkorn, Inc.
Report dateApr 4, 2018
Recall initiation dateMar 29, 2018
Quantity56,1800 unit dose cups
LocationLake Forest, IL, United States

Official product description

Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cups (NDC 50383-720-15) packaged in 100-count (10 x 10) cups per case pack (NDC 50383-720-18 or 50383-720-19), Rx Only, Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701.

Why the product was recalled

Subpotent Drug: Product crystallization with accompanying low out of specification results for chlorhexidine assay.

Distribution information

Nationwide in the USA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.